West Paces Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

West Paces Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.49K	Buy	+103	New	+$3.43K	﹤0.01%	499

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

West Paces Advisors's TEVA Position: Q2 2026 in Review

West Paces Advisors opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 103 shares worth $3.49K. The stake represents ﹤0.01% of the portfolio and ranks #499 among its holdings.

676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

West Paces Advisors held 103 shares of Teva Pharmaceutical Industries Limited worth $3.49K as of Q2 2026.
Teva Pharmaceutical Industries Limited was a new West Paces Advisors position in Q2 2026.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of West Paces Advisors's portfolio in Q2 2026, its #499 holding.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.